retatrutide trial update The numbers from Lilly's Phase 3 dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user TRIUMPH-1 Trial Results: Retatrutide for

Stay hydrated and maintain balanced meals in the days before your first injection

External resources New England Journal of Medicine: Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2 trial) PMC: Switching between GLP-1 receptor agonists, rationale and practical guidance Endocrine Practice: Switching to tirzepatide from GLP-1 receptor agonists, clinical expectations PMC: The risk of vestibular disorders with semaglutide and tirzepatide In case I do not see you, good afternoon, good evening, and good night

Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72

Can Yeast Infections Occur Anywhere Else on the Body

upregulation of BDNF may contribute towards the neuroprotective effects in the once-a-day fed CR group (Fig